NCT05469594

Brief Summary

In France, the recently adopted law relating to the legal time limit for access to voluntary interruption of pregnancy has set a threshold of the term at which it can be performed up to 16 weeks of gestation. This single-centre study conduced at the Nancy Maternity Hospital is based on a retrospective cohort of all patients who underwent a medical termination of pregnancy between January 2010 and October 2021. The main objective is to evaluate the complications according to the term of the termination of pregnancy between two groups : \[12-14\] vs \[14-16\] weeks of gestation. The secondary objective is the distribution of these complications between the two groups. Pregnancy termination can be performed in two methods, either by medical method with mifepristone and misoprostol, or by surgical method by dilation and evacuation. Complications identified are haemorrhage, infection, retained product of trophoblast, uterine rupture and abortion induction failure. The hypothesis is the concomitant increase in complications with the term of the termination of pregnancy.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
122

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2010

Longer than P75 for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2010

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2010

Completed
11.8 years until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2021

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

July 11, 2022

Completed
10 days until next milestone

First Posted

Study publicly available on registry

July 21, 2022

Completed
Last Updated

July 21, 2022

Status Verified

July 1, 2022

Enrollment Period

Same day

First QC Date

July 11, 2022

Last Update Submit

July 20, 2022

Conditions

Keywords

complications

Outcome Measures

Primary Outcomes (1)

  • complications

    hemorrhage, infection, retained product of conception, failure, uterine rupture

    Day 0

Secondary Outcomes (1)

  • repartition of all complications

    Day 0

Study Arms (2)

Termination of pregnancy between 12-14 weeks of gestation

Termination of pregnancy between 14-16 weeks of gestation

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

women of childbearing age, major, with a single pregnancy who underwent for termination of pregnancy for medical reasons (maternal or foetal) between 12 and 16 weeks of gestation.

You may qualify if:

  • termination of pregnancy for a medical reason
  • between 12 and 16 weeks of gestation
  • singleton pregnancy

You may not qualify if:

  • multiple pregnancy
  • abortion occurred before the induction of termination of pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Specialist assistant in gynaecology and obstetrics

Study Record Dates

First Submitted

July 11, 2022

First Posted

July 21, 2022

Study Start

January 1, 2010

Primary Completion

January 1, 2010

Study Completion

October 1, 2021

Last Updated

July 21, 2022

Record last verified: 2022-07